Ars Technica
US · 30 mins ago
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
The vaccine reportedly thwarted the cancer's return and spread.
Do you trust Ars Technica?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!